what dose do you start on tirzepatide dosage chart: Zepbound and Mounjaro What dose do you start

The pain keeps coming back or gets worse over time This could mean that the body is reacting to the medication, or there might be another health issue involved

Other risk factors that may increase vulnerability include: Long duration of diabetes (typically more than 10 years) Poor glycaemic control prior to starting GLP-1 therapy (HbA1c significantly above target) Rapid reduction in HbA1c (a drop of more than 2 percentage points [22 mmol/mol] within 36 months) Concurrent hypertension , especially if poorly controlled Diabetic kidney disease (nephropathy), which often correlates with retinopathy severity Previous history of retinal treatment (laser photocoagulation or intravitreal injections) People with type 2 diabetes but no retinopathy appear to have minimal risk of retinopathy progression based on current evidence

Documented symptomatic hypoglycaemia (according to ADA classification) [22] was also low (three subjects [five events] in the moderate renal impairment group and two subjects [two events] in the severe renal impairment group)

Vrktjer som tabs- og indsatsgrnser, realitetstjek, sessionstidsml og let adgang til selvudelukkelse er essentielle

Injecting expired or improperly stored medication may be less effective and unsafe